Cordero García J M, Delgado Portela M, García Vicente A M, Pilkington Woll J P, Palomar Muñoz M A, Poblete García V M, Bellón Guardia M E, Pardo García R, Rabadán Ruiz L, Soriano Castrejón A M
Servicio de Medicina Nuclear, Hospital General de Ciudad Real, Ciudad Real, España.
Rev Esp Med Nucl. 2010 May-Jun;29(3):122-6. doi: 10.1016/j.remn.2010.03.001. Epub 2010 Apr 15.
The study of the sentinel node has made it possible to obtain more comprehensive knowledge about the extent of axillary involvement in breast cancer. It has also decreased the surgical morbidity associated to the surgical examination of the axilla. The systematic use of immunohistochemical staining and molecular biology techniques improves the ability to detect the presence of micrometastasis or isolated tumor cells in a significant number of cases when this is the only sign of the lymph node extension of the disease. The possibility of avoiding complete axillary lymphadenectomy in those patients who are only affected by micrometastasis is proposed because of the low incidence of further involvement of the remaining lymph nodes.
159 patients diagnosed of stage T1 or T2 breast cancer, in which the sentinel node had been identified by scintigraphy and intraoperative localization, were included in the study. Complete axillary lymphadenectomy was performed when micro- or macrometastases were found in the sentinel node, in order to determine the degree of axillary involvement.
A total of 40 patients (25%) showed infiltration of the sentinel node. This infiltration was only by micrometastasis in 17 of them (10.7%). Of these 17 patients, only 2 (11.8%) showed macro-metastasis in the lymphadenectomy. In the remaining subjects, the final staging reached after the sentinel node study was not modified.
It is possible to speculate that, in the future, axillary dissection can be avoided in those patients diagnosed of micrometastasis in the sentinel node, pending the conclusions of the on-going multicenter studies.
前哨淋巴结的研究使人们能够更全面地了解乳腺癌腋窝受累的程度。它还降低了与腋窝手术检查相关的手术发病率。当疾病的淋巴结转移仅表现为微转移或孤立肿瘤细胞时,系统使用免疫组化染色和分子生物学技术可提高在大量病例中检测其存在的能力。由于其余淋巴结进一步受累的发生率较低,因此建议对仅受微转移影响的患者避免进行完整的腋窝淋巴结清扫术。
本研究纳入了159例诊断为T1或T2期乳腺癌的患者,这些患者通过闪烁显像和术中定位确定了前哨淋巴结。当前哨淋巴结发现微转移或宏转移时,进行完整的腋窝淋巴结清扫术,以确定腋窝受累程度。
共有40例患者(25%)显示前哨淋巴结浸润。其中17例(10.7%)仅为微转移浸润。在这17例患者中,只有2例(11.8%)在淋巴结清扫术中显示宏转移。在其余患者中,前哨淋巴结研究后的最终分期未改变。
可以推测,在未来,对于诊断为前哨淋巴结微转移的患者,在正在进行的多中心研究得出结论之前,可以避免腋窝清扫术。